nach oben

Clinical Drug Investigation

Erschienen in:

01.07.2000 | Case Report

Possible Drug Interaction Between Digoxin and Azithromycin in a Young Child

verfasst von: Andrew P. Ten Eick, Denver Sallee, Tamar Preminger, Amanda Weiss, Dr Michael D. Reed

Erschienen in: Clinical Drug Investigation | Ausgabe 1/2000

Einloggen, um Zugang zu erhalten

Excerpt

Because of the relatively narrow therapeutic range for digoxin, medications altering digoxin bioavailability or clearance may predispose the patient to intoxication. Although drug-drug interactions between the macrolide antibacterials (e.g. erythromycin and clarithromycin) and digoxin have been described previously,[1] there have been no published descriptions of drug-drug interactions occurring with digoxin and the azilide antibacterial azithromycin. We report a case of digoxin intoxication occurring in a young patient who was concurrently receiving digoxin and azithromycin. …

Bizjak ED, Mauro VF. Digoxin-macrolide drug interaction. Ann Pharmacother 1997; 31: 1077–9PubMed

Lindenbaum J, Rund DG, Butler VP, et al. Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. N Engl J Med 1981; 305: 789–94PubMedCrossRef

Dobkin JF, Butler VP, Lindenbaum J. Digoxin-inactivating bacteria: identification in human gut flora. Science 1983; 220: 325–7CrossRef

Park MK. Use of digoxin in infants and children, with specific emphasis on dosage. J Pediatr 1986; 108: 871–7PubMedCrossRef

Kelly RA, Smith TW. Recognition and management of digitalis toxicity. Am J Cardiol 1992; 69: 108G–118GPubMedCrossRef

Reed MD, Blumer JL. Azithromycin: a critical review of the first azilide antibiotic and its role in pediatric practice. Pediatr Infect Dis J 1997; 16: 1069–83PubMedCrossRef

Takano M, Hasegawa R, Fukuda T, et al. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. Eur J Pharmacol 1998; 358: 289–94PubMedCrossRef

Wakasugi H, Yano I, Ito T, et al. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clin Pharmacol Ther 1998; 64: 123–8PubMedCrossRef

Van Asperen J, Van Tellingen O, Beijnen JH. The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacological Res 1998; 27: 429–35CrossRef

10.

Greiner B, Eichelbaum M, Fritz P, et al. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 1999; 104: 147–53PubMedCrossRef

11.

Walsh EP, Saul JP, Sholler GF, et al. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997; 29: 1046–53PubMedCrossRef

12.

Yeh BK, Tao P, DeGuzman N. Mobitz type II A-V block as a manifestation of digitalis toxicity. J Electrocardiol 1972; 5(1): 74–7PubMedCrossRef

13.

Rosen KM, Loeb HS, Gunnar RM, et al. Mobitz type II block without bundle-branch block. Circulation 1971 Dec; 44(6): 1111–9PubMedCrossRef

14.

Larese RJ, Mirkin BL. Kinetics of digoxin absorption and relation of serum levels to cardiac arrhythmias in children. Clin Pharmacol Ther 1974; 15: 387–96PubMed

15.

Nicholson PW, Dobbs SM, Rodgers EM. Ideal sampling time for drug assays. Br J Clin Pharmacol 1980; 9: 467–70PubMedCrossRef

16.

Hastreiter AR, van der Horst RL, Voda C, et al. Maintenance digoxin dosage and steady-state plasma concentration in infants and children. J Pediatr 1985; 107: 140–6PubMedCrossRef

Titel: Possible Drug Interaction Between Digoxin and Azithromycin in a Young Child
verfasst von: Andrew P. Ten Eick
Denver Sallee
Tamar Preminger
Amanda Weiss
Dr Michael D. Reed
Publikationsdatum: 01.07.2000
Verlag: Springer International Publishing
Erschienen in: Clinical Drug Investigation / Ausgabe 1/2000
Print ISSN: 1173-2563
Elektronische ISSN: 1179-1918
DOI: https://doi.org/10.2165/00044011-200020010-00008

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Possible Drug Interaction Between Digoxin and Azithromycin in a Young Child

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2000

Plasmodium falciparum Kinetics during Treatment with Antimalarial Drugs in Children

Moxonidine and Ramipril in Patients with Hypertension and Obstructive Pulmonary Disease

Saturable Active Tubular Reabsorption in the Renal Clearance of Mesalazine in Human Volunteers

In vitro Comparison of Three Salbutamol-Containing Multidose Dry Powder Inhalers

Inhaled Triamcinolone Acetonide HFA 450μg Twice Daily Compared with Beclomethasone Dipropionate CFC 500μg Twice Daily in Adults with Moderate Persistent Asthma

Furosemide as a Fetal Growth Promoter